Cryptococcal meningitis in a patient treated with infliximab

被引：28

作者：

Munoz, Patricia

Giannella, Maddalena

Valerio, Maricela

Soria, Teresa

Diaz, Fernando

Longo, Javier Lopez

Bouza, Emilio

机构：

[1] Univ Madrid, Hosp Gen Gregorio Maranon, Dept Clin Microbiol & Infect Dis, E-28007 Madrid, Spain

[2] Univ Roma La Sapienza, Policlin Umberto I, Dept Clin Med, Rome, Italy

[3] Univ Madrid, Hosp Gen Gregorio Maranon, Dept Neurol, E-28007 Madrid, Spain

[4] Univ Madrid, Hosp Gen Gregorio Maranon, Dept Rheumatol, E-28007 Madrid, Spain

来源：

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE | 2007年 / 57卷 / 04期

关键词：

infliximab; Cryptococcus neoformans; rheumatoid arthritis; immunosuppressed host; meningitis; pneumonia;

D O I：

10.1016/j.diagmicrobio.2006.10.014

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

Infliximab, a tumor necrosis factor-alpha inhibitor, is increasingly used for the therapy of different inflammatory conditions. We report the first case of cryptococcal meningitis in a patient treated with infliximab and other immunosuppressive agents, and review a further 5 reported cryptococcal infections. All of them involved fungal pneumonia. Outcome was favorable in all cases. (c) 2007 Elsevier Inc. All rights reserved.

引用

收藏

页码：443 / 446

页数：4

相关论文

共 23 条

[1] Cavitating pneumonia after treatment with infliximab and prednisone [J].

Arend, SM ;

Kuijper, EJ ;

Allaart, CF ;

Muller, WH ;

van Dissel, JT .

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2004, 23 (08) :638-641

[2]

Casadevall A, 1998, CRYPTOCOCCUS NEOFORM, P47

[3] FALSE-NEGATIVE CEREBROSPINAL-FLUID CRYPTOCOCCAL LATEX AGGLUTINATION TESTS FOR PATIENTS WITH CULTURE-POSITIVE CRYPTOCOCCAL MENINGITIS [J].

CURRIE, BP ;

FREUNDLICH, LF ;

SOTO, MA ;

CASADEVALL, A .

JOURNAL OF CLINICAL MICROBIOLOGY, 1993, 31 (09) :2519-2522

[4] SERUM CRYPTOCOCCAL ANTIGEN DETERMINATION IN THE PRESENCE OF RHEUMATOID-FACTOR [J].

ENG, RHK ;

PERSON, A .

JOURNAL OF CLINICAL MICROBIOLOGY, 1981, 14 (06) :700-702

[5] Does safety make a difference in selecting the right TNF antagonist? [J].

Fleischmann, R ;

Yocum, D .

ARTHRITIS RESEARCH & THERAPY, 2004, 6 (Suppl 2) :S12-S18

[6] Pulmonary cryptococcosis after initiation of anti-tumor necrosis factor-α therapy [J].

Hage, CA ;

Wood, KL ;

Winer-Muram, TH ;

Wilson, SJ ;

Sarosi, G ;

Knox, KS .

CHEST, 2003, 124 (06) :2395-2397

[7] Contribution of tumour necrosis factor-alpha (TNF-alpha) in host defence mechanism against Cryptococcus neoformans [J].

Kawakami, K ;

Qifeng, X ;

Tohyama, M ;

Qureshi, MH ;

Saito, A .

CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1996, 106 (03) :468-474

[8] EVALUATION OF NEW MONOCLONAL ANTIBODY-BASED LATEX AGGLUTINATION-TEST FOR DETECTION OF CRYPTOCOCCAL POLYSACCHARIDE ANTIGEN IN SERUM AND CEREBROSPINAL-FLUID [J].

KISKA, DL ;

ORKISZEWSKI, DR ;

HOWELL, D ;

GILLIGAN, PH .

JOURNAL OF CLINICAL MICROBIOLOGY, 1994, 32 (09) :2309-2311

[9] Life-threatening histoplasmosis complicating immunotherapy with tumor necrosis factor α antagonists infliximab and etanercept [J].

Lee, JH ;

Slifman, NR ;

Gershon, SK ;

Edwards, ET ;

Schwieterman, WD ;

Siegel, JN ;

Wise, RP ;

Brown, SL ;

Udall, JN ;

Braun, MM .

ARTHRITIS AND RHEUMATISM, 2002, 46 (10) :2565-2570

[10] Cryptococcal antigen test revisited: Significance for cryptococcal meningitis therapy monitoring in a tertiary Chinese hospital [J].

Lu, HZ ;

Zhou, YJ ;

Yin, YK ;

Pan, XZ ;

Weng, XH .

JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (06) :2989-2990